Response to docetaxel and cisplatin induction chemotherapy of locally advanced head and neck squamous cell carcinoma: a multicenter, non-comparative, open-label interventional pilot study
Vanita Noronha, Kumar Prabhash(Homi Bhabha National Institute), Vedang Murthy(Homi Bhabha National Institute), Amit Joshi(Dr. Rajendra Prasad Government Medical College), S. Arya(Tata Memorial Hospital), S. Goud(HCG Cancer Hospital), S. Patil(HCG Cancer Hospital), C. Goswami(Medical College and Hospital, Kolkata), S Juvekar(Tata Memorial Hospital), Vijay Patil
Cited by 10
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340